Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk.
Jingjing ZhuXiang ShuXingyi GuoDuo LiuJian-Dong BaoJonathan BeesleyGraham G GilesChong WuMengmeng DuEmily WhiteHarvey A RischNúria MalatsEric Jeffrey DuellPhyllis J GoodmanDounghui LiPaige BracciVerena A KatzkeRachel E NealeSteven GallingerStephen K Van den EedenAlan A ArslanFrederico CanzianCharles KooperbergLaura E Beane FreemanGhislaine SceloKala VisvanathanChristopher A HaimanLoïc Le MarchandHerbert YuGloria M PetersenRachael Stolzenberg-SolomonAlison P KleinQiuyin CaiJirong LongWei ZhengLang WuPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
This study identifies novel protein biomarker candidates for PDAC, which if validated by additional studies, may contribute to the etiologic understanding of PDAC development.